VXB-12324-61818
4 vaccinations
5 coded responses
44 check-ins
5 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 752 / TX
- Registered
- 2021-03-10
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-10
Registered in v-safe
-
2021-03-10
Dose 1 — Pfizer-BioNTech
- 2021-03-10
- 2021-03-11
- 2021-03-13
- 2021-03-14
-
2021-03-15
Health check-in — days 1–6 daily, dose 1Feeling: Good · Rash, not including the immediate area around the injection siteAdult check-in
- 2021-03-16
- 2021-03-17
- 2021-03-24
-
2021-03-30
Dose 2 — Pfizer-BioNTech
- 2021-03-30
-
2021-03-31
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-04-01
Survey response — days 1–6 daily, dose 2MedDRA: Insomnia — Feeling: Good · Site: Pain · Fever · Muscle or body aches, Fatigue or tirednessFree text: InsomniaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-02
Survey response — days 1–6 daily, dose 2MedDRA: Injection site bruising — Feeling: Good · Site: PainFree text: Bruising around injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-03
Survey response — days 1–6 daily, dose 2MedDRA: Injection site bruising — Feeling: GoodFree text: Bruise around injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-04
- 2021-04-05
- 2021-04-06
- 2021-04-13
- 2021-04-20
- 2021-04-27
- 2021-05-04
- 2021-05-13
- 2021-06-29
-
2021-09-28
Survey response — 6 months, dose 2MedDRA: Nasopharyngitis, SARS-CoV-2 test negative, Sinusitis — Feeling: Good · Be unable to do your normal daily activitiesFree text: Really bad cold followed by sinus infection. Negative COVID 19 test result. Overall illness lasted 3 weeks.MedDRA releases: 2024-11 · check-in free text available
-
2021-12-09
Dose 3 — ModernaCo-administered: Flu
-
2021-12-10
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
- 2021-12-12
- 2021-12-13
- 2021-12-14
- 2021-12-15
- 2021-12-16
- 2021-12-23
- 2021-12-30
- 2022-01-06
- 2022-01-13
- 2022-01-20
- 2022-03-10
-
2022-06-09
Survey response — 6 months, dose 3MedDRA: Nasopharyngitis — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Common coldMedDRA releases: 2024-11 · check-in free text available
-
2022-10-10
Dose 4 — Moderna
- 2022-10-13
- 2022-10-15
- 2022-10-16
- 2022-10-17
- 2022-11-09
- 2022-11-21
- 2023-01-11
- 2023-04-12
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-10 | Pfizer-BioNTech | |
| 2 | 2021-03-30 | Pfizer-BioNTech | |
| 3 | 2021-12-09 | Moderna | Flu |
| 4 | 2022-10-10 | Moderna | No |
Free text
Release 6 — days 1–6 daily, dose 2
Systemic reaction (other): Insomnia
Systemic reaction (other): Bruising around injection site
Systemic reaction (other): Bruise around injection site
Release 9 — 6 months, dose 2
Symptoms: Really bad cold followed by sinus infection. Negative COVID 19 test result. Overall illness lasted 3 weeks.
Release 12 — 6 months, dose 3
Symptoms: Common cold
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nasopharyngitis | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | Sinusitis | · | · | ✓ |
| SRO | Injection site bruising | ✓ | ✓ | ✓ |
| SRO | Insomnia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release